612
Views
19
CrossRef citations to date
0
Altmetric
Report

Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas

Pages 749-761 | Received 13 Nov 2013, Accepted 28 Dec 2013, Published online: 06 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Fanyan Meng & Guojun Wu. (2014) Novel mechanism links p63 and cisplatin resistance. Cell Cycle 13:6, pages 881-881.
Read now

Articles from other publishers (17)

Anne-Marie Baird & Steven G. Gray. 2023. Epigenetic Cancer Therapy. Epigenetic Cancer Therapy 577 611 .
Cristian Prieto-Garcia, Oliver Hartmann, Michaela Reissland, Thomas Fischer, Carina R. Maier, Mathias Rosenfeldt, Christina Schülein-Völk, Kevin Klann, Reinhard Kalb, Ivan Dikic, Christian Münch & Markus E. Diefenbacher. (2021) Inhibition of USP28 overcomes Cisplatin-resistance of squamous tumors by suppression of the Fanconi anemia pathway. Cell Death & Differentiation 29:3, pages 568-584.
Crossref
Jia‐Hui Guo, Hai‐Yun Fang, Jun‐Mei Yang, Shan‐Ling Liu, Qiang‐Hua Yao, Yi‐Juan Fan, Mei Zhao, Feng Liu, Quan‐Wu Zhang & Feng‐Hou Gao. (2020) MicroRNA ‐92b acts as an oncogene by targeting PTEN / AKT in NSCLC . Cell Biochemistry and Function 38:8, pages 1100-1110.
Crossref
Mei Yi, Yixin Tan, Li Wang, Jing Cai, Xiaoling Li, Zhaoyang Zeng, Wei Xiong, Guiyuan Li, Xiayu Li, Pingqing Tan & Bo Xiang. (2020) TP63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development. Cellular and Molecular Life Sciences 77:21, pages 4325-4346.
Crossref
Dong Hoon Lee, Go Woon Kim, Yu Hyun Jeon, Jung Yoo, Sang Wu Lee & So Hee Kwon. (2020) Advances in histone demethylase KDM4 as cancer therapeutic targets. The FASEB Journal 34:3, pages 3461-3484.
Crossref
Amjad A. Aljagthmi, Natasha T. Hill, Mariana Cooke, Marcelo G. Kazanietz, Martín C. Abba, Weiwen Long & Madhavi P. Kadakia. (2019) ΔNp63α suppresses cells invasion by downregulating PKCγ/Rac1 signaling through miR-320a. Cell Death & Disease 10:9.
Crossref
Michael A. Moses, Andrea L. George, Nozomi Sakakibara, Kanwal Mahmood, Roshini M. Ponnamperuma, Kathryn E. King & Wendy C. Weinberg. (2019) Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis. International Journal of Molecular Sciences 20:14, pages 3590.
Crossref
Maria Rovira-Rigau, Giulia Raimondi, Miguel Ángel Marín, Meritxell Gironella, Ramon Alemany & Cristina Fillat. (2019) Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic Cancer. Molecular Therapy 27:1, pages 230-243.
Crossref
Meng Wang, Wen-Run Cai, Ran Meng, Jiang-Rui Chi, Yun-Rui Li, Ao-Xiang Chen, Yue Yu & Xu-Chen Cao. (2018) miR-485-5p suppresses breast cancer progression and chemosensitivity by targeting survivin. Biochemical and Biophysical Research Communications 501:1, pages 48-54.
Crossref
Manmei Long, Ming Zhan, Sunwang Xu, Ruimeng Yang, Wei Chen, Shilei Zhang, Yongheng Shi, Qiao He, Man Mohan, Qiang Liu & Jian Wang. (2017) miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer. Molecular Cancer 16:1.
Crossref
Jing Dai, Hao Wu, Yi Zhang, Kai Gao, Gui Hu, Yihang guo, Changwei Lin & Xiaorong Li. (2016) Negative feedback between TAp63 and Mir-133b mediates colorectal cancer suppression. Oncotarget 7:52, pages 87147-87160.
Crossref
Peng Zhou, Fan Zeng, Jun Liu, Dan Lv & Shixi Liu. (2016) Correlation between miR-21 expression and laryngeal carcinoma risks: a meta-analysis. Journal of Evidence-Based Medicine 9:1, pages 32-37.
Crossref
Bernadette M. Boac, Yin Xiong, Douglas C. Marchion, Forough Abbasi, Stephen H. Bush, Ingrid J. Ramirez, Beman R. Khulpateea, E. Clair McClung, Amy L. Berry, Nadim Bou Zgheib, Hye Sook Chon, Mian M. Shahzad, Patricia L. Judson, Robert M. Wenham, Sachin M. Apte, Anders E. Berglund, Anthony M. Magliocco & Johnathan M. Lancaster. (2016) Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance. Gynecologic Oncology 140:2, pages 259-263.
Crossref
Edward A. Ratovitski. (2015) Phospho‐ΔNp63α‐responsive microRNAs contribute to the regulation of necroptosis in squamous cell carcinoma upon cisplatin exposure. FEBS Letters 589:12, pages 1352-1358.
Crossref
Changwei Lin, Xiaorong Li, Yi Zhang, Yihang Guo, Jianyu Zhou, Kai Gao, Jing Dai, Gui Hu, Lv Lv, Juan Du & Yi Zhang. (2015) The microRNA feedback regulation of p63 in cancer progression. Oncotarget 6:11, pages 8434-8453.
Crossref
Sujit Nair & Ah-Ng Tony Kong. (2015) Architecture of Signature miRNA Regulatory Networks in Cancer Chemoprevention. Current Pharmacology Reports 1:2, pages 89-101.
Crossref
Steven G. Gray. 2015. Epigenetic Cancer Therapy. Epigenetic Cancer Therapy 613 637 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.